On June 3, 2021 Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, reported that its CEO, Dr James Garner, will be presenting virtually at the upcoming LD Micro Invitational XI (Press release, Kazia Therapeutics, JUN 3, 2021, View Source [SID1234583492]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Dr Garner commented, "this is a particularly exciting time for Kazia, with our lead program, paxalisib, now well-advanced in a pivotal study, and a promising new program, EVT801, due to enter the clinic this year. We look forward to updating the attendees on our progress, and on the rich slate of news flow anticipated for the second half of the year."
Event:
Kazia Presentation at the LD Micro Invitational XI
Date:
Wednesday 9 June 2021
Time:
5pm, Eastern Time
Investors may register for free to attend the event by using the following link:-
The 2021 LD Micro Invitational will be held on the Sequire Virtual Events platform on Tuesday, June 8th – Thursday, June 10th, 2021, running from 7:00 AM PT – 3:00 PM PT / 10:00 AM ET – 6:00 PM ET each day.
This three-day, virtual investor conference is expected to feature around 180 companies, presenting for 25 minutes each, as well as several influential keynotes. The first day of this conference will also feature an exceptional one-time event: the LD Micro Hall of Fame.